Ang Yong Guan v Singapore Medical Council and another matter [2024] SGHC 126

Case Details

• Citation: [2024] SGHC 126
• Court: General Division of the High Court (Court of Three Judges)
• Decision Date: 13 May 2024
• Coram: Sundaresh Menon CJ, Tay Yong Kwang JCA, Belinda Ang Saw Ean JCA
• Case Number: Originating Application No 8 of 2023; Originating Application No 9 of 2023
• Hearing Date(s): 16 November 2023
• Appellants: Ang Yong Guan; Singapore Medical Council
• Respondents: Singapore Medical Council; Ang Yong Guan
• Counsel for Appellant in OA 8: Christopher Chong Fook Choy, Sim Mei Jun Andrey, Sia Tian Wa Jeremy Marc (Dentons Rodyk & Davidson LLP) and Chandra Mohan K Nair (Tan Rajah & Cheah LLP)
• Counsel for Respondent in OA 8: Kronenburg Edmund Jerome, Colin Wu Guolin, Nicole Lee Man Ruo and Chan Yu Jie (Braddell Brothers LLP)
• Practice Areas: Professions — Medical profession and practice — Professional conduct

Summary

In Ang Yong Guan v Singapore Medical Council and another matter [2024] SGHC 126, the Court of Three Judges addressed the critical threshold between professional misconduct under section 53(1)(d) of the Medical Registration Act (Cap 174, 2014 Rev Ed) ("MRA") and the failure to provide professional services of a reasonable quality under section 53(1)(e). The dispute arose from the psychiatric treatment and prescribing practices of Dr. Ang Yong Guan ("Dr. Ang") regarding the late Mr. Quek Kiat Siong ("the Patient"), who died of mixed drug intoxication involving medications prescribed by Dr. Ang. The Disciplinary Tribunal ("DT") had initially acquitted Dr. Ang of professional misconduct, opting instead to convict him on alternative charges of failing to provide professional services of the requisite quality. The Singapore Medical Council ("SMC") appealed this acquittal, while Dr. Ang appealed his convictions.

The central doctrinal contribution of this judgment lies in the Court’s clarification of the "intentional, deliberate departure" standard established in Low Cze Hong v Singapore Medical Council [2008] 3 SLR(R) 612. The Court held that professional misconduct is established where a practitioner makes a conscious choice to depart from applicable standards, regardless of whether they intended to cause harm or believed their actions were in the patient's best interest. The Court emphasized that while Ministry of Health ("MOH") guidelines and product inserts are not absolute "statutes" for medical practice, they represent the standards approved by the profession. A practitioner who chooses to deviate from these standards bears an evidential burden to justify the departure through a rigorous risk-benefit analysis and, where appropriate, informed consent from the patient.

The Court ultimately reversed the DT’s decision, finding that Dr. Ang’s conduct indeed constituted professional misconduct. The Court found that Dr. Ang had knowingly prescribed dosages of Mirtazapine and Zolpidem Controlled Release ("Zolpidem CR") that significantly exceeded the maximum limits specified in product inserts and MOH guidelines. Furthermore, his practice of prescribing multiple benzodiazepines concurrently and in quantities intended for long-term chronic use—contrary to established clinical guidelines—was found to be an intentional departure from the standards of the profession. The judgment serves as a stern reminder that "care and concern" for a patient cannot override the objective requirements of clinical safety and professional standards.

The broader significance of this case for the Singapore legal landscape is its reinforcement of the objective nature of professional disciplinary standards. It clarifies that the "1st Limb" of the Low Cze Hong test focuses on the intentionality of the act of departure from the standard, rather than a subjective intent to be "misconducted." By convicting Dr. Ang of professional misconduct, the Court underscored that serious deviations from safety-critical guidelines, even when motivated by a desire to help a difficult patient, undermine the standing of the medical profession and necessitate the highest level of disciplinary scrutiny.

Timeline of Events

1. 8 February 2010: The Patient first consulted Dr. Ang for psychiatric treatment.
2. 21 March 2010: Dr. Ang prescribed a daily dosage of 60mg of Mirtazapine, exceeding the 45mg maximum limit.
3. 28 April 2010: Dr. Ang prescribed a daily dosage of 25mg of Zolpidem CR, exceeding the 12.5mg maximum limit.
4. 5 May 2010: Dr. Ang continued the excessive prescription of 60mg Mirtazapine.
5. 16 May 2010: Dr. Ang continued the excessive prescription of 25mg Zolpidem CR.
6. 17 May 2010: Dr. Ang continued the excessive prescription of 60mg Mirtazapine.
7. 31 December 2011: End of a period during which Dr. Ang was alleged to have failed to ensure antidepressants were continued for 4 to 6 weeks before switching.
8. 1 January 2012: Commencement of the period (until 2 July 2012) where Dr. Ang allegedly prescribed multiple benzodiazepines concurrently.
9. 2 July 2012: End of the period of concurrent benzodiazepine prescription.
10. 4 July 2012: Dr. Ang prescribed a 6-month supply of benzodiazepines (Bromazepam and Midazolam) for long-term chronic use.
11. 31 July 2012: Dr. Ang issued the final prescriptions to the Patient.
12. 4 August 2012: The Patient passed away due to multi-organ failure with pulmonary haemorrhage, caused by mixed drug intoxication.
13. 2 February 2017: High Court judgment in the related civil proceedings (Quek Kwee Kee Victoria v AIA).
14. 11 April 2017: Court of Appeal judgment in the related civil proceedings.
15. 2023: The Disciplinary Tribunal issued its decision in [2023] SMCDT 2, acquitting Dr. Ang of misconduct but convicting him of professional services charges.
16. 16 November 2023: Substantive hearing of the cross-appeals before the Court of Three Judges.
17. 13 May 2024: The Court of Three Judges delivered its judgment, convicting Dr. Ang of professional misconduct.

What Were the Facts of This Case?

Dr. Ang Yong Guan is a registered psychiatrist in Singapore. The Patient, the late Mr. Quek Kiat Siong, first sought treatment from Dr. Ang on 8 February 2010. Over the course of approximately two and a half years, Dr. Ang treated the Patient for a complex array of psychiatric conditions, including insomnia, depression, post-traumatic stress disorder, obsessional ruminations, and anxiety. The Patient was described as a difficult and demanding individual who frequently requested specific medications and dosages to manage his symptoms.

The disciplinary proceedings centered on three pairs of charges. The first pair of charges (Charge 1 and Alternative Charge 1) alleged that between 8 February 2010 and 31 December 2011, Dr. Ang failed to ensure that antidepressants were continued for at least 4 to 6 weeks before switching to another antidepressant. It further alleged that between 1 January 2012 and 2 July 2012, Dr. Ang prescribed two or more benzodiazepines concurrently (specifically Bromazepam and Midazolam) without adequate justification. These practices were alleged to be contrary to the MOH Clinical Practice Guidelines on Depression and the MOH Clinical Practice Guidelines on Prescribing of Benzodiazepines.

The second pair of charges (Charge 2 and Alternative Charge 2) concerned a prescription issued on 4 July 2012. Dr. Ang prescribed a 6-month supply of benzodiazepines, specifically 540 tablets of Bromazepam (3mg) and 360 tablets of Midazolam (15mg). The SMC alleged this constituted prescribing for long-term chronic use, which exceeded the recommended limit of 2 to 4 weeks for short-term relief and intermittent use as stipulated in the MOH Guidelines on Benzodiazepines. The SMC argued that such long-term use carried significant risks of dependence and tolerance.

The third pair of charges (Charge 3 and Alternative Charge 3) related to specific instances in 2010 where Dr. Ang prescribed medications in dosages exceeding the maximum limits set out in product inserts and MOH guidelines. On 21 March 2010, 5 May 2010, and 17 May 2010, Dr. Ang prescribed 60mg of Mirtazapine daily, while the permitted maximum was 45mg. On 28 April 2010 and 16 May 2010, he prescribed 25mg of Zolpidem CR daily, while the permitted maximum was 12.5mg. The SMC contended that these excessive dosages were unsafe and lacked clinical justification.

Tragically, the Patient passed away on 4 August 2012. The cause of death was multi-organ failure with pulmonary haemorrhage due to mixed drug intoxication. Post-mortem toxicological reports revealed elevated concentrations of Mirtazapine and Bromazepam in the Patient's blood. While the related civil proceedings (Quek Kwee Kee Victoria (executrix of the estate of Quek Kiat Siong, deceased) and another v American International Assurance Co Ltd and another [2016] 3 SLR 93) determined that the Patient had likely not committed suicide but had ingested the drugs as prescribed, the focus of the disciplinary proceedings was on whether Dr. Ang's prescribing conduct itself met the threshold of professional misconduct or a failure to provide reasonable quality services.

During the DT hearing, Dr. Ang relied on the expert evidence of Dr. Ng Beng Yong, a practising psychiatrist. Dr. Ng argued that Dr. Ang’s treatment was "individualised" for a treatment-resistant patient and that the departures from guidelines were justified by the Patient's specific clinical needs and the "care and concern" Dr. Ang showed in managing a difficult case. The DT accepted that Dr. Ang did not intend to harm the Patient and was motivated by care, leading to the acquittal on the misconduct charges (s 53(1)(d)) and conviction on the lesser charges (s 53(1)(e)). The SMC challenged this, arguing that the intentional nature of the departures from standards necessitated a conviction for professional misconduct.

What Were the Key Legal Issues?

The primary legal issue was the proper interpretation and application of the two limbs of the test for professional misconduct under section 53(1)(d) of the Medical Registration Act. Specifically, the Court had to determine:

• The "Intentional Departure" Standard: Whether Dr. Ang’s conduct constituted an "intentional, deliberate departure from standards observed or approved by members of the profession of good repute and competency" (the 1st Limb of the Low Cze Hong test). This involved deciding if the "intent" required relates to the act of departing from the standard or an intent to commit misconduct.
• The Status of MOH Guidelines: To what extent do MOH Clinical Practice Guidelines and product inserts constitute "standards observed or approved by members of the profession," and under what circumstances can a practitioner justify a departure from them?
• The Distinction between Section 53(1)(d) and 53(1)(e): How the court should distinguish between "professional misconduct" (which implies a higher level of culpability) and the "failure to provide professional services of the quality that it is reasonable to expect" (which is often equated with serious negligence).
• The Role of Subjective Motivation: Whether a doctor's subjective "care and concern" or lack of intent to cause harm can serve as a defense against a charge of professional misconduct when an objective, intentional departure from safety standards is proven.

How Did the Court Analyse the Issues?

The Court of Three Judges began its analysis by revisiting the foundational test for professional misconduct in Singapore. Under Low Cze Hong v Singapore Medical Council [2008] 3 SLR(R) 612, professional misconduct can be established in two ways. The "1st Limb" involves an "intentional, deliberate departure from the standards observed or approved by members of the profession of good repute and competency." The "2nd Limb" involves "serious negligence" that falls far short of the standard of care. The Court noted that the DT had acquitted Dr. Ang because it found no "dishonesty" or "intent to do wrong," effectively importing a requirement of mens rea for misconduct that the Court found to be erroneous.

The Court clarified that the 1st Limb of Low Cze Hong does not require an intent to cause harm or a subjective realization that one is committing misconduct. Instead, it requires that the practitioner intended the act that constitutes the departure from the standard. As the Court observed:

"professional misconduct may be made out where... there is an intentional, deliberate departure from the standards observed or approved by members of the profession of good repute and competency" (at [8]).

In analyzing the MOH Guidelines and product inserts, the Court rejected the notion that they are merely "administrative" or "optional." While they are not rigid rules, they represent the collective wisdom and approved standards of the medical community. The Court held that if a doctor chooses to depart from these standards, the evidential burden shifts to the doctor to justify that departure. This justification must be based on a "responsible body of medical opinion" (applying the Bolam-Bolitho test as endorsed in Khoo James and another v Gunapathy d/o Muniandy and another appeal [2002] 1 SLR(R) 1024). Specifically, the doctor must show they considered the rationale of the standard, performed a risk-benefit analysis, and concluded the departure was in the patient's best interest.

The Court then applied this framework to the specific charges against Dr. Ang:

1. Excessive Dosages (Charge 3): The Court found that Dr. Ang was fully aware of the maximum dosages for Mirtazapine (45mg) and Zolpidem CR (12.5mg). He intentionally chose to prescribe 60mg and 25mg respectively. The Court noted that these limits are set for safety reasons. Dr. Ang’s justification—that the Patient was "treatment-resistant"—was insufficient because he failed to document a rigorous risk-benefit analysis or demonstrate that such high doses were supported by a responsible body of psychiatric opinion. The Court held that this was a clear, intentional departure from approved standards.

2. Concurrent Benzodiazepines and Long-term Supply (Charges 1 and 2): The Court examined the MOH Guidelines on Benzodiazepines, which explicitly warn against the "long-term chronic use" of these drugs due to the risk of dependence. Dr. Ang’s prescription of a 6-month supply was a "flagrant" departure from the guideline recommending use for only 2 to 4 weeks. The Court emphasized that the guidelines were designed to prevent the very type of drug dependency that the Patient appeared to have developed. The Court found that Dr. Ang’s decision to provide such a large supply, even if done to accommodate a demanding patient, was a deliberate choice to ignore the safety standards of the profession.

3. The "Care and Concern" Defense: The Court addressed the DT’s finding that Dr. Ang acted out of "care and concern." The Court held that while a doctor’s motives are relevant to sentencing, they cannot excuse an intentional departure from safety standards. Professional misconduct is an objective standard. A doctor who "kindly" prescribes a dangerous dose is still guilty of misconduct because they have compromised the standards that protect the public and the reputation of the profession. The Court cited Singapore Medical Council v Looi Kok Poh and another matter [2019] 5 SLR 456, noting that care and concern must be expressed within the boundaries of professional standards.

4. Section 53(1)(e) vs Section 53(1)(d): The Court clarified the relationship between these two sections. Section 53(1)(e) (failure to provide professional services of reasonable quality) is often the appropriate charge for "serious negligence" (the 2nd Limb of Low Cze Hong). However, where the departure is intentional and deliberate, it falls squarely within section 53(1)(d) as professional misconduct. The Court referred to Ho Tze Woon v Singapore Medical Council [2023] SGHC 254, noting that the test for s 53(1)(e) is whether the conduct was "manifestly below" the expected standard. In Dr. Ang's case, because he knew the standards and chose to depart from them, the higher charge of misconduct was appropriate.

What Was the Outcome?

The Court of Three Judges allowed the SMC’s appeal in OA 9 and set aside the DT’s acquittal of Dr. Ang on the professional misconduct charges. Consequently, the Court dismissed Dr. Ang’s appeal in OA 8 against his convictions on the alternative charges, as the primary charges of professional misconduct were now sustained. The Court found Dr. Ang guilty of all three charges of professional misconduct under section 53(1)(d) of the MRA.

The operative conclusion of the Court was stated as follows:

"For these reasons, we find that all three professional misconduct charges are made out, save that in respect of the first two charges, it is to the limited extent set out above. We will hear the parties on the question of the appropriate sanctions and, in due course, on costs." (at [151])

The "limited extent" referred to by the Court involved specific nuances in the timeline and the exact nature of the concurrent prescriptions, but the core finding of professional misconduct remained for all three heads of the SMC's complaint. The Court deferred the determination of sanctions and costs to a subsequent phase, requiring further submissions from the parties. The conviction on the section 53(1)(d) charges represents a significantly more serious disciplinary outcome for Dr. Ang than the DT's initial findings under section 53(1)(e).

Why Does This Case Matter?

This judgment is a landmark decision in Singapore medical law for its rigorous enforcement of clinical guidelines as the benchmark for professional conduct. It clarifies that the "intentional, deliberate departure" standard for professional misconduct is an objective one. Practitioners cannot shield themselves from disciplinary liability by claiming they acted with good intentions or that they were simply trying to help a difficult patient. If a doctor knows a standard exists—such as a maximum dosage in a product insert or a restriction on prescribing duration in an MOH guideline—and chooses to ignore it, they are at high risk of a professional misconduct conviction.

For practitioners, the case establishes a clear "evidential burden" framework. While the law recognizes that medicine is not always "one size fits all," any deviation from established guidelines must be justified by a contemporaneous, documented risk-benefit analysis. The Court’s reliance on Khoo James and another v Gunapathy [2002] 1 SLR(R) 1024 reinforces that such justifications must be able to withstand logical scrutiny and be supported by a responsible body of medical opinion. This places a premium on detailed clinical note-taking and the use of formal peer consultation when embarking on "off-label" or "off-guideline" treatments.

Furthermore, the case highlights the disciplinary dangers of "patient-led" prescribing. Dr. Ang’s desire to appease a demanding patient led him to prescribe dosages and quantities that were objectively unsafe. The Court of Three Judges has made it clear that the doctor’s duty to maintain professional standards and ensure patient safety overrides the patient’s requests, even in complex psychiatric cases. This protects the integrity of the medical profession by ensuring that the "standards observed or approved by members of the profession" are not diluted by individual practitioners' subjective motivations.

Finally, the judgment provides much-needed clarity on the interplay between sections 53(1)(d) and 53(1)(e) of the MRA. By aligning the "1st Limb" of Low Cze Hong with section 53(1)(d), the Court has provided a clearer roadmap for the SMC and Disciplinary Tribunals in framing and adjudicating charges. It signals that intentionality in the act of departure is the key differentiator that elevates a case from "serious negligence" to "professional misconduct."

Practice Pointers

• Treat Guidelines as Rebuttable Presumptions: Practitioners should treat MOH Clinical Practice Guidelines and product inserts as the "approved standards." While not absolute, any departure requires a robust, evidence-based justification that can be defended before a peer tribunal.
• Document Risk-Benefit Analyses: When choosing to deviate from standard dosages or prescribing durations, doctors must document their rationale, the specific risks considered, and why the potential benefits outweigh those risks for that specific patient.
• Avoid Patient-Led Prescribing: Do not allow a patient's demands or "treatment resistance" to justify prescribing practices that fall outside safety limits. The duty to the profession and the public's safety is paramount.
• Understand "Intentional Departure": Professional misconduct does not require an intent to do "evil." It simply requires a conscious decision to act in a way that departs from the standard. Good motives (care and concern) are not a defense to the charge itself.
• Limit Long-Term Benzodiazepines: Strictly adhere to guidelines regarding the duration of benzodiazepine prescriptions. If long-term use is necessary, it must be closely monitored and the justification clearly recorded, avoiding large-quantity "bulk" prescriptions.
• Heed Product Inserts: Maximum dosages specified in product inserts are critical safety benchmarks. Exceeding them without overwhelming clinical evidence and peer support is a high-risk activity that likely constitutes misconduct.
• Obtain Informed Consent for Deviations: If a departure from standard guidelines is planned, ensure the patient is fully informed of the risks of the non-standard treatment and that this consent is documented.

Subsequent Treatment

As a 2024 decision from the Court of Three Judges, this case represents the current authoritative word on the "intentional departure" limb of professional misconduct. It reinforces the ratio that a medical practitioner bears the evidential burden to justify departures from codified standards (like MOH guidelines) on clear, objective medical grounds. It has been cited to emphasize that "care and concern" cannot substitute for adherence to safety standards and that the threshold for misconduct is met when a practitioner knowingly chooses to bypass established clinical safeguards.

Legislation Referenced

• Medical Registration Act (Cap 174, 2014 Rev Ed), sections 53(1)(d), 53(1)(e), 55(11)
• SMC Ethical Code and Ethical Guidelines

Cases Cited

• Applied:
  • Low Cze Hong v Singapore Medical Council [2008] 3 SLR(R) 612
• Referred to:
  • Ho Tze Woon v Singapore Medical Council [2023] SGHC 254
  • Quek Kwee Kee Victoria (executrix of the estate of Quek Kiat Siong, deceased) and another v American International Assurance Co Ltd and another [2016] 3 SLR 93
  • Quek Kwee Kee Victoria (executor of the estate of Quek Kiat Siong, deceased) and another v American International Assurance Co Ltd and another [2017] 1 SLR 461
  • Singapore Medical Council v Lim Lian Arn [2019] 5 SLR 739
  • Yong Thiam Look Peter v Singapore Medical Council [2017] 4 SLR 66
  • Gobinathan Devathasan v Singapore Medical Council [2010] 2 SLR 926
  • Huang Danmin v Traditional Chinese Medicine Practitioners Board [2010] 3 SLR 1108
  • Jen Shek Wei v Singapore Medical Council [2018] 3 SLR 943
  • Ang Pek San Lawrence v Singapore Medical Council [2015] 1 SLR 436
  • Singapore Medical Council v Looi Kok Poh and another matter [2019] 5 SLR 456
  • Wee Teong Boo v Singapore Medical Council (Attorney-General, intervener) [2023] 3 SLR 705
  • Khoo James and another v Gunapathy d/o Muniandy and another appeal [2002] 1 SLR(R) 1024
  • Ang Peng Tiam v Singapore Medical Council and another matter [2017] 5 SLR 356
  • Hii Chii Kok v Ooi Peng Jin London Lucien and another [2017] 2 SLR 492
  • Singapore Medical Council v Wong Him Choon [2016] 4 SLR 1086
  • Bolitho v City and Hackney Health Authority [1998] AC 232

Source Documents

• Original judgment PDF: Download (PDF, hosted on Legal Wires CDN)
• Official eLitigation record: View on elitigation.sg